WASHINGTON, D.C., June 10 /PRNewswire-FirstCall/ -- A new study demonstrated that even a small percentage of weight loss could lower health care costs among people with type 2 diabetes. Data from the study, titled “Short Term Economic Impact of Weight Change Among Patients with Type 2 Diabetes,” were presented today at the 66th Annual Scientific Sessions of the American Diabetes Association (ADA) in Washington, DC. The study was funded by an unrestricted research grant from Amylin Pharmaceuticals, Inc. and Eli Lilly and Company to Analysis Group, Inc.
